Skin and Connective Tissue Diseases

445 trials 165 recruiting

Filter these 445 trials by phase, country and sponsor.

Open in Search →

A Phase 3, Multicentre, Randomised, Double-blind, Vehicle-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Tirbanibul… Ended

2023-505487-11-00 Actinic Keratosis on the Face or Scalp 5 2023-12-21
Hidradenitis Suppurativa Phase 3 Study of Izokibep Ended

2022-503160-33-00 Hidradenitis Suppurativa 5 2023-12-15
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors Ended

2022-502348-11-00 Pancreatic Neoplasms 1 2023-12-15
A multicenter, Phase 1b, double-blind, placebo-controlled study to evaluate the safety and tolerability, and the efficacy of si-544 in adult… Ended

2023-507393-40-00 psoriasis vulgaris 3 2023-12-12
In vivo bioequivalence study of a new clobetasol propionate 0.05% topical cream compared to DERMOVAL® 0.05% cream using the skin blanching b… Ended

2023-504879-24-00 corticosteroid-sensitive dermatosis 2 2023-12-12
A randomized, double-blind, placebo-controlled, multicenter, adaptive phase III trial to investigate the efficacy and safety of vilobelimab … Ended

2023-506250-20-00 ulcerative pyoderma gangrenosum 5 2023-12-11
A randomized, placebo-controlled clinical trial to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, pharmacodynamics and… Ended

2023-503577-38-00 Atopic Dermatitis 1 2023-12-07
Moisturiser effect on the skin barrier in atopic dermatitis Ended

2023-508560-29-00 Atopic dermatitis 4 2023-12-07
This is a clinical trial (study), to be conducted in several clinical sites worldwide, of an oral study drug which will be investigated in a… Ended

2023-503957-36-00 Moderate-to-Severe pruritus in adult subjects with nota 10 2023-12-04
Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria Ended

2022-503062-72-00 Chronic Spontaneous Urticaria 4 2023-11-23
A study to evaluate the efficacy and safety of Clascoterone solution in treatment of male pattern hair loss. Ended

2023-504421-39-00 Androgenetic Alopecia 5 2023-11-21
A bioequivalence vasoconstriction study comparing two clobetasol propionate 0.5 mg/g ointments after skin application in healthy adult human… Ended

2023-504707-87-00 Localized, therapy-resistant inflammatory skin diseases 2 2023-11-20
A trial to evaluate the efficacy and safety of different doses of LEO 138559 in adults with moderate-to-severe atopic dermatitis. Ended

2022-500777-14-00 Atopic Dermatitis 4 2023-11-06
A Phase 3b, Open-label Study to Evaluate the Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-S… Ended

2023-505558-16-00 Atopic Dermatitis 5 2023-10-24
Pilot study RCT anti-TNF Adalimumab versus placebo in fasciotomy Dupuytren contracture Ended

2023-503701-11-00 Dupuytren Disease 5 2023-10-16
A study to test whether spesolimab helps people with a skin disease called hidradenitis suppurativa Ended

2022-501074-19-00 Hidradenitis suppurativa 10 2023-10-13
Orchid 1 Ended

2023-503516-32-00 Vulvar lichen sclerosus (VLS) 4 2023-10-12
Study of GS-5718 in Participants With Cutaneous Lupus Erythematosus (CLE) Ended

2022-501523-24-00 Cutaneous Lupus Erythematosus (CLE) 4 2023-10-12
A Phase 2, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label E… Ended

2022-502827-23-00 Chronic Hand Eczema 4 2023-10-12
A Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis Ended

2022-501621-20-00 Prurigo Nodularis 5 2023-10-02
An open label, randomized, three-period, three-sequence, crossover bioavailability study to assess the pharmacokinetic and safety profile of… Ended

2023-504760-42-00 Not applicable (submitted trial is a bioequivalence stu 2 2023-09-27
BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria Ended

2024-514764-72-00 Chronic Urticaria 5 2023-09-27
Exploratory study to determine the tolerability and effectiveness of Tirbanibulin in the treatment of Actinic Cheilitis - Cheilitis trial Ended

2022-502807-31-00 Actinic Cheilitis 4 2023-09-26
Treatment of Chronic Hand Eczema with Oral Roflumilast (HERO) Ended

2022-503011-42-00 Chronic hand eczema 4 2023-09-25